Agenda

Department of Anesthesiology and Pain Medicine University of California, Davis
Saturday October 3, 2020 at 6:00 p.m. - 7:30 p.m. (Eastern Time)
Zoom Meeting by invitation only

Welcome/Department Overview – Richard L. Applegate II M.D., FASA

6:00 p.m. - 6:10 p.m.

Design and Optimization of Biologics as Therapeutic Candidates for the Treatment of Chronic Pain – Vladimir Yarov-Yarovoy, Ph.D.

6:10 p.m. - 6:40 p.m.

Open House – David Copenhaver, M.D., MPH

6:40 p.m. - 7:20 p.m.

Closing Remarks – Julie Gardner, M.D.

7:20 p.m. - 7:30 p.m.

Note: The event will be at 6:00 p.m. - 7:30 p.m. Eastern Time (3:00 p.m. - 4:30 p.m.)

 

Registration is required and is now open, complete here

 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Anesthesiologists and the Indiana Society of Anesthesiologists. The American Society of Anesthesiologists is accredited by the ACCME to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

 
Jointly provided by the American Society of Anesthesiologists and the UC Davis Department of Anesthesiology and Pain Medicine

 

Statement of Need:
Practitioners need to understand the role of specific channel receptors that may present potential targets for chronic pain treatment and what molecules may be candidates for future therapeutic agents to treat chronic pain patients.


Target Audience
This course is designed for anesthesiologists, physicians, and any other research professionals associated with ambulatory anesthesia.


Learning Objectives
Upon completion of this activity, learners will be able to:

  • discuss the NIH HEAL Initiative funded project's goal to optimize potent, selective peptide inhibitors of human voltage-gated sodium channels for chronic pain treatment.

  • describe the importance of high-resolution structures of human voltage-gated channel for optimization of potent and selective peptide mimics as therapeutic candidates for chronic pain treatment.

  • recognize the importance of Rosetta computational approaches for in silico optimization of high affinity, specificity, and stability of peptide mimics as therapeutic candidates for chronic pain treatment.

Disclosure Policy
The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.


Disclosures

Name

Type of Relationship

Company

Richard L. Applegate ll M.D.

Consulting Fees, Funded Research

Massimo, Merck


All other planners, faculty, and staff have disclosed no relevant financial relationships with commercial interests.


Disclaimer
The information provided at this accredited activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Anesthesiologists and UC Davis Department of Anesthesiology and Pain Medicine. The American Society of Anesthesiologists is accredited by the ACCME to provide continuing medical education for physicians. The American Society of Anesthesiologists designates this live activity for a maximum of .50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Maintenance of Certification in AnesthesiologyTM program and MOCA® are registered trademarks of The American Board of Anesthesiology®. MOCA 2.0® is a trademark of the American Board of Anesthesiology®.


Claiming Credit
Please follow these directions to complete the evaluation, claim your credit and print your certificate. The date on your certificate will reflect the date upon which you claim credit. The certificate can only be claimed once.

Click the following link and log in using your ASA credentials: 2020 UC DAVIS Design and Optimization of Biologics

Complete the evaluation, claim credits, and print your certificate.

OR

Log in to the ASA Education Center at: http://education.asahq.org/.

Once you have logged on to the ASA Education Center homepage, click the tab that says “MY COURSES” to select the link: 2020 UC DAVIS Design and Optimization of Biologics

Complete the evaluation, claim credits, and print your certificate.

NOTE: To retrieve your username and/or password, enter your email address at: https://www.asahq.org/member-center/forgot-password

PLEASE NOTE: You can only claim credit one time and you must claim your credits for this course by December 31, 2020. You will NOT be able to claim credits after this date.